LAPAROSCOPIC CHOLECYSTECTOMY IN ANTICOAGULATED PATIENTS

被引:16
作者
FITZGERALD, SD [1 ]
BAILEY, PV [1 ]
LIEBSCHER, GJ [1 ]
ANDRUS, CH [1 ]
机构
[1] ST LOUIS UNIV,SCH MED,DEPT SURG,3635 VISTA & GRAND BLVD,POB 15250,ST LOUIS,MO 63110
来源
SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES | 1991年 / 5卷 / 04期
关键词
CHOLECYSTECTOMY; LAPAROSCOPY; ANTICOAGULATION; HEART VALVE; PROSTHESIS; ATRIAL FIBRILLATION;
D O I
10.1007/BF02653254
中图分类号
R61 [外科手术学];
学科分类号
摘要
Although minimally surgically invasive, laparoscopic surgery has yet to be proven safe in patients receiving anticoagulants. Retrospectively, the laparoscopic management of four patients requiring anticoagulation for cardiac valvular prostheses or chronic atrial fibrillation was reviewed with regard to potential hemorrhagic complications. Warfarin was discontinued preoperatively in all cases. Heparin anticoagulation was individualized according to each patient's risk for thrombosis. Laparoscopic cholecystectomy and intraoperative cholangiography were completed in each patient without resulting hemorrhagic complications. The operative management of patients exhibiting cholecystitis may be complicated by anticoagulation therapy required for preexisting conditions/diseases such as cardiac valve prostheses, chronic atrial fibrillation, deep venous thrombosis, and pulmonary embolism. The minimally invasive nature of laparoscopic surgery lends itself well to cholecystectomy required in the face of anticoagulation treatment. This limited initial series of selected patients demonstrates the feasibility and efficacy of laparoscopic cholecystectomy in patients receiving anticoagulants.
引用
收藏
页码:166 / 169
页数:4
相关论文
共 7 条
  • [1] Blatner M., Wittgen C.M., Andrus C.H., Kaminski D.L., Cystic duct cholangiography during laparoscopic cholecystectomy, Arch Surg, 126, pp. 646-649, (1991)
  • [2] Hasson H.M., Phillips J.M., Open laparoscopy, Laparo- scopy, pp. 145-149, (1977)
  • [3] Katholi R.E., Nolan S.P., McGuire L.B., Living with prosthetic valves: subsequent noncardiac operations and risk of thromboem- bolism or hemorrhage, Am Heart J, 92, pp. 162-167, (1976)
  • [4] Majerus P.W., Broze G.J., Miletich J., Tollefsen D.M., Anticoagu- lation, thrombolytic, and antiplatelet drugs, The pharmacological basis of therapeutics, pp. 311-331, (1990)
  • [5] Tinker J.H., Tarhan S., Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses, JAMA, 239, pp. 738-739, (1978)
  • [6] Tinker J.H., Noback C.R., Vlietstra R.E., Frye R.L., Management of patients with heart disease for non-cardiac surgery, JAMA, 246, (1981)
  • [7] Travis S., Wray R., Harrison K., Perioperative anticoagulant control, Br J Surg, 76, pp. 1107-1108, (1989)